INTACT Program for Alzheimer's Disease
(INTACT Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on collecting data from patient records rather than changing treatments.
What data supports the effectiveness of the INTACT Program treatment for Alzheimer's disease?
The Alzheimer's and Dementia Care Program (ADC Program) is a comprehensive care model that has been effective in providing care for Alzheimer's disease, and similar structured education and follow-up interventions have shown positive outcomes for both patients and caregivers. Additionally, programs that include multimodal interventions have demonstrated promise in supporting and improving the quality of life for individuals in the early stages of Alzheimer's disease.12345
How is the INTACT Program treatment for Alzheimer's disease different from other treatments?
The INTACT Program is unique because it focuses on training caregivers and healthcare providers to improve care for Alzheimer's patients, rather than being a medication or direct medical intervention. This approach emphasizes education and skill-building to enhance the quality of care and support for individuals with Alzheimer's disease.16789
What is the purpose of this trial?
INTACT will utilize a group-randomized trial, to test the effectiveness of a culturally informed provider training and "dementia friendly clinic" intervention for detection and appropriate management of AI/AN patients with ADRD and MCI in 28 urban and rural clinics serving AI/ANs.
Eligibility Criteria
This trial is for healthcare providers in clinics serving American Indian/Alaska Native (AI/AN) communities. It aims to improve the detection and management of Alzheimer's Disease and related dementias (ADRD) as well as mild cognitive impairment (MCI).Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
The INTACT program is implemented, including PCP training, quarterly webinars, and a workflow model for cognitive evaluation
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Waitlist Control
Clinics in the wait-list arm will have the opportunity to receive the INTACT intervention after the initial 12-month study period
Treatment Details
Interventions
- INTACT Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington State University
Lead Sponsor
University of Miami
Collaborator
University of Washington
Collaborator
University of Minnesota
Collaborator